UMIN ID: UMIN000054546
Registered date:02/06/2024
Circulating Tumor DNA for Predicting Occult Metastases in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
Basic Information
Recruitment status | Complete: follow-up continuing |
---|---|
Health condition(s) or Problem(s) studied | Resectable and borderline resectable pancreatic ductal adenocarcinoma |
Date of first enrollment | 2019/05/01 |
Target sample size | 130 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Association of preoperative ctDNA and occult metastases |
---|---|
Secondary Outcome | Association of preoperative ctDNA and prognosis |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | 85years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1) Patients with pathologically carcinoma in situ or complete response by neoadjuvant therapy 2) Patients with active cancer |
Related Information
Primary Sponsor | Sapporo medical university |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | None |
Secondary ID(s) |
Contact
public contact | |
Name | Takeshi Murakami |
Address | South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-0061, Japan Japan 060-8556 |
Telephone | 0116112111 |
murakami.takeshi@sapmed.ac.jp | |
Affiliation | Sapporo Medical University Department of Surgery, Surgical Oncology and Science |
scientific contact | |
Name | Takeshi Murakami |
Address | South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-0061, Japan Japan |
Telephone | 0116112111 |
murakami.takeshi@sapmed.ac.jp | |
Affiliation | Sapporo Medical University Department of Surgery, Surgical Oncology and Science |